3Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction[J]. Circulation, 1995, 92(6) : 1558-1564.
4Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans[J]. Horm Metab Res, 1999,31(9):487- 498.
5Richards A M, Nicbolls M G, Yandle T G, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predietors of left ventricular function and prognosis after myocardial infarction[J]. Circulation, 1998,97 (19) :1921-1929.
6Maisel A S, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J]. Am Heart J, 2001,141(3) : 367-374.
9[1]Maisel AS, Koon J, Krishnaswamy P, et al. Utility of Bnatriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J,2001,141(3): 367-374
10[2]Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol, 2001.,37:379-385
2Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure[J]. Circulation,2006,113(6) : 671-678.
3Singer E, Mark5 L, Paragas N, et al. Neutrophil gelatinase associated lipocalin pathophysiology and clinical applications [J]. Acta Physiol(Oxf), 2013,207(4) : 663-672.
4Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program[J]. Clin Chem, 2006,52(1) : 5-18.
5Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase- associated lipocalin (NGAL) as a biomarker for acute renal injury a{ter cardiac surgery[J]. Lancet, 2005,365 (9466) : 1231- 1238.
6Chowdhury P, Choudhary R, Maisel A. The appropriate use of biomarkers in heart faiiure[-J2. Med Clin North Am, 2012, 96 (5) : 901-913.
7Alvelos M, Lourenco P, Dias C, et al. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure [J]. Int J Cardiol,2013,165(1):51-55.
8Daniels LB, Barrett-Connor E, Clopton P, et al. Plasma neutrophil gelatinaseassociated lipoealin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: the Rancho Bernardo Study [J]. J Am Coll Cardiol,2012,59(12) :1101-1109.
